We could not find any results for:
Make sure your spelling is correct or try broadening your search.
The current IONS market cap is 6.06B. The company's latest EPS is USD -2.5131 and P/E is -16.55.
Quarter End | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 |
---|---|---|---|---|---|
USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
Total Revenue | 159.77M | 151.89M | 130.52M | 188.41M | 144.21M |
Operating Income | -59.16M | -208.02M | -114.15M | -90.2M | -143.26M |
Net Income | -46.99M | -52.43M | -124.32M | -85.29M | -147.41M |
Year End 31 December 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|
USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
Total Revenue | 1.12B | 729.26M | 810.46M | 587.37M | 787.65M |
Operating Income | 365.88M | -172.08M | -30.19M | -410.19M | -353.73M |
Net Income | 294.15M | -451.29M | -28.6M | -269.72M | -366.29M |
Quarter End | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 |
---|---|---|---|---|---|
USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
Total Assets | 2.42B | 2.53B | 2.89B | 2.97B | 2.93B |
Total Liabilities | 1.83B | 1.96B | 2.4B | 2.54B | 2.62B |
Total Equity | 594.36M | 572.89M | 486.57M | 428.3M | 315.46M |
Year End 31 December 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|
USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
Total Assets | 3.23B | 2.39B | 2.61B | 2.53B | 2.99B |
Total Liabilities | 1.55B | 1.55B | 1.84B | 1.96B | 2.6B |
Total Equity | 1.68B | 843.35M | 771.74M | 572.89M | 386.69M |
Quarter End | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 |
---|---|---|---|---|---|
USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
Operating | -74.18M | -274.37M | -133.99M | -231.36M | -340.38M |
Investing | -474.78M | -262.64M | -325.64M | -256.13M | -187.41M |
Financing | -4.28M | -55.3M | 492.09M | 635.63M | 603.36M |
Year End 31 December 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|
USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
Operating | 345.72M | 35.89M | 30.8M | -274.37M | -307.51M |
Investing | -41.27M | 274.48M | 194.91M | -262.64M | -214.13M |
Financing | 100.02M | -596.61M | 245.93M | -55.3M | 644.08M |
Market Cap | 6.06B |
Price to Earnings Ratio | -16.55 |
Price to Sales Ratio | 7.7 |
Price to Cash Ratio | 15.19 |
Price to Book Ratio | 15.68 |
Dividend Yield | - |
Shares Outstanding | 145.75M |
Average Volume (1 week) | 806.59k |
Average Volume (1 Month) | 896.33k |
52 Week Change | 15.53% |
52 Week High | 54.4446 |
52 Week Low | 34.32 |
Spread (Intraday) | 7.98 (16.51%) |
Company Name | Ionis Pharmaceuticals Inc |
Address |
corporation trust center wilmington, delaware 19801 |
Website | https://www.isispharm.com |
Industry | pharmaceutical preparations (2834) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions